BioScience Health Innovations (BHIC) EBITDA (2020 - 2026)
BioScience Health Innovations' (BHIC) quarterly EBITDA came in at -$217882.0 in Q2 2026, down 147.6% year-over-year from $457704.0 in Q2 2025, and up 5.23% quarter-over-quarter from -$229907.0 in Q1 2026.
Powered by 
Analysis
BioScience Health Innovations (BHIC) EBITDA (2020 - 2026) Analysis & Trends
BioScience Health Innovations (BHIC) has reported EBITDA for 7 consecutive years, with -$217882.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA fell 147.6% year-over-year to -$217882.0 in Q2 2026; TTM through Jun 2026 was -$613240.0, a 164.51% decrease from a year earlier, with the FY2025 full-year figure at $719051.0, up 726.5% from the prior year.
- EBITDA was -$217882.0 for Q2 2026 at BioScience Health Innovations, up from -$229907.0 in the prior quarter.
- Over five years, EBITDA peaked at $457704.0 in Q2 2025 and troughed at -$229907.0 in Q1 2026.
- A 5-year average of $0.72 and a median of -$33646.5 in 2022 frame the typical range for EBITDA.
- The widest YoY moves for EBITDA: up 899.53% in 2025, down 1673.46% in 2025.
- Over 5 years, EBITDA stood at -$28917.0 in 2022, then plunged by 32.71% to -$38376.0 in 2023, then soared by 125.95% to $9957.0 in 2024, then plunged by 1673.46% to -$156669.0 in 2025, then sank by 39.07% to -$217882.0 in 2026.
- The last three EBITDA figures came in at -$217882.0 (Q2 2026), -$229907.0 (Q1 2026), and -$156669.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Blackstone | 103.57 Bn | 101.06 Bn | - | 2.95 Bn |
| 2 | Kkr | 93.46 Bn | -183.61 Bn | - | 2.04 Bn |
| 3 | Apollo Global Management | 77.60 Bn | 52.22 Bn | 10.54 Bn | 5.35 Bn |
| 4 | Brookfield Asset Management | 76.45 Bn | 74.94 Bn | - | 1.39 Bn |
| 5 | Wheaton Precious Metals | 71.34 Bn | 71.24 Bn | 687.86 Mn | 789.56 Mn |
| 6 | Franco Nevada | 51.21 Bn | 49.67 Bn | 451.00 Mn | 445.70 Mn |
| 7 | Brookfield | 37.98 Bn | 7.42 Bn | 19.38 Bn | 34.32 Bn |
| 8 | Ares Management | 30.49 Bn | 30.49 Bn | - | 490.27 Mn |
| 9 | Carlyle | 15.82 Bn | 14.57 Bn | - | 312.00 Mn |
| 10 | BioScience Health Innovations | 64.26 Mn | 63.55 Mn | 659,483.00 | -217,882.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -217,882.00 |
| Mar 31, 2026 | -229,907.00 |
| Dec 31, 2025 | -156,669.00 |
| Sep 30, 2025 | -8,782.00 |
| Jun 30, 2025 | 457,704.00 |
| Mar 31, 2025 | 426,798.00 |
| Dec 31, 2024 | 9,957.00 |
| Sep 30, 2024 | 56,202.00 |
| Jun 30, 2024 | 74,222.00 |
| Mar 31, 2024 | -53,381.00 |
| Dec 31, 2023 | -38,376.00 |
| Sep 30, 2023 | -57,146.00 |
| Jun 30, 2023 | -85,262.00 |
| Mar 31, 2023 | -70,716.00 |
| Nov 30, 2022 | -28,917.00 |
| Aug 31, 2022 | -3,708.00 |
| May 31, 2022 | -47,884.00 |
| Feb 28, 2022 | -26,240.00 |
| Nov 30, 2021 | -14,089.00 |
| Aug 31, 2021 | -4,155.00 |